Insider's sale of shares at a lower price may suggest belief in the stock's full valuation. However, this is a weak sign and doesn't definitively indicate their view on the stock's value. The lack of insider buying recently and history of sales make us cautious about the stock.
Columbus McKinnon's high P/E compared to the market appears justified due to expected earnings growth and potential EPS increase. This is anticipated to strongly support the share price, barring changes in circumstances.
BOFA •$Oscar Health(OSCR.US)$BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...
Upgrades •$美源伯根(ABC.US)$: Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175) •$Alignment Healthcare(ALHC.US)$: BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18) •$信諾(CI.US)$: BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265) •$加拿大國家鐵路(CNI.US)$: Evercore ISI Upgrades to Outperform from In Line •$有道(DAO.US)$: Citic Securities Upgrades to Buy from Neut...
哥倫布-麥金農股票討論區
5年來毛利率基本在34%左右,還不錯。淨資產收益率從5.9%上升到13.4%後直接下滑到1.8%,2021年恢復到4.6%,比較差勁。
5年來營收、營業利潤前三年變化不大,2021年暴跌,2022年部分恢復。
5年來經營淨額累計低於投資淨額,沒有股東盈餘。
目前市盈率31.6,市盈率TTM 20.5,即使按2020年6千萬淨利潤高點計算,目前市盈率也達到15.7,沒有吸引力。
• $Oscar Health(OSCR.US)$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...
• $美源伯根(ABC.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare(ALHC.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $信諾(CI.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $加拿大國家鐵路(CNI.US)$ : Evercore ISI Upgrades to Outperform from In Line
• $有道(DAO.US)$ : Citic Securities Upgrades to Buy from Neut...
暫無評論